Skip to content
← Back to this collection

PUBLICATIONS · 34780709

Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2021 Dec
First author
Fischer M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 Dec;22(12):1646-1648. doi: 10.1016/S1470-2045(21)00608-2.
    note
    Source null
    related pmid
    34780708
    relationship
    Comment in

Authors and identifiers

  1. name
    Fischer M
    type
    Author
  2. name
    Moreno L
    type
    Author
  3. name
    Ziegler DS
    type
    Author
  4. name
    Marshall LV
    type
    Author
  5. name
    Zwaan CM
    type
    Author
  6. name
    Irwin MS
    type
    Author
  7. name
    Casanova M
    type
    Author
  8. name
    Sabado C
    type
    Author
  9. name
    Wulff B
    type
    Author
  10. name
    Stegert M
    type
    Author
  11. name
    Wang L
    type
    Author
  12. name
    Hurtado FK
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Fischer M
    type
    Author
  2. name
    Moreno L
    type
    Author
  3. name
    Ziegler DS
    type
    Author
  4. name
    Marshall LV
    type
    Author
  5. name
    Zwaan CM
    type
    Author
  6. name
    Irwin MS
    type
    Author
  7. name
    Casanova M
    type
    Author
  8. name
    Sabado C
    type
    Author
  9. name
    Wulff B
    type
    Author
  10. name
    Stegert M
    type
    Author
  11. name
    Wang L
    type
    Author
  12. name
    Hurtado FK
    type
    Author
bibliography ids
  1. nci-bib-027b957724a4d78bf19ff2b7
book metadata
content sha256
6efcb42b7b2ddad869b0d2e6d88d28a473436aec7cb0d898c340451e6ba27702
document type
citation
dois
  1. 10.1016/S1470-2045(21)00536-2
electronic publication date
display
2021 Nov 12
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34780709
immutable id
pubmed:34780709@6efcb42b7b2ddad869b0d2e6d88d28a473436aec7cb0d898c340451e6ba27702
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
12
name
The Lancet. Oncology
nlm unique id
100957246
pages
1764-1776
volume
22
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 Dec;22(12):1646-1648. doi: 10.1016/S1470-2045(21)00608-2.
    note
    Source null
    related pmid
    34780708
    relationship
    Comment in
outcomes validated
false
pmid
34780709
provenance
batch id
3f4d1914d2afe41e9e70
provider
NCBI PubMed ESummary
record sha256
006f89c9aa63083d6f70876d76e7267afdc70fbb0c74820438c9ad96e1832785
response sha256
0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
retrieved at
2026-09-09T23:48:06.522634+00:00
publication date
display
2021 Dec
precision
month
year
2021
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34780709/
title
Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study.

Preserved source evidence · Not medical advice